Jadranka Bozikov

Prof. Dr. Jadranka Bozikov

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Science and Engineering Ethics
Verified
Journal Article
Closed access
PDF file
MMMatko Marušić
Matko Marušić
JBJadranka Bozikov
Jadranka Bozikov
VKVedran Katavić
Vedran Katavić
DHDarko Hren
Darko Hren
MKMarko Kljaković-Gašpić
Marko Kljaković-Gašpić
AMAna Marušić
Ana Marušić

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SGStojanka Gašparović
Stojanka Gašparović
NRNadan Rustemović
Nadan Rustemović
MOMilorad Opačić
Milorad Opačić
MPMarina Premužić
Marina Premužić
AKAnđelko Korušić
Anđelko Korušić
TBTamara Bates
Tamara Bates
Clinical analysis of propofol deep sedation for 1,104 patients undergoing gastrointestinal endoscopic procedures: A three year prospective study

1 March 1991 in International Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
BVBoris Vucelić
Boris Vucelić
BKBojana Korać
Bojana Korać
MSMirna Sentić
Mirna Sentić
DMDavor Miličić
Davor Miličić
NHNijaz Hadžić
Nijaz Hadžić
NMNikola Makek
Nikola Makek
A ten-year prospective study of Crohn's disease was carried out in Zagreb, Yugoslavia. It included both inpatients and outpatients regardless of the extent and severity of the disease. The mean annual incidence rate was 0.7 per 100 000 between 1 January 1980 and 31 December 1989. There was no increase in the incidence of Crohn's disease during the study period. The prevalence of Crohn's disease was 8.3 per 100 000 on 31 December 1989. The results confirm the low frequency of Crohn's disease in central and southern Europe.

1 December 1991 in International Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
BVBoris Vuceljć
Boris Vuceljć
BKBojana Korać
Bojana Korać
MSMirna Sentić
Mirna Sentić
DMDavor Millličlć
Davor Millličlć
NHNijaz Hadžić
Nijaz Hadžić
NMNikola Makek
Nikola Makek
We present a ten-year incidence of ulcerative colitis in Zagreb, Yugoslavia. The study included both outpatients and inpatients regardless of the extent and severity of the disease. The mean annual incidence rate was 1.5 per 100000 inhabitants for the period of 1 January 1980 through 31 December 1989. There was no increase in the incidence of ulcerative colitis during the study period. A prevalence rate estimate of 21.4 per 100000 inhabitants was based on Jury 1985 official estimated population. The results confirm the low frequency of ulcerative colitis in central Europe.

1 May 2002 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
IMIvan Malčić
Ivan Malčić
MJMarija Jelušić
Marija Jelušić
HKHrvoje Kniewald
Hrvoje Kniewald
NBNina Barišić
Nina Barišić
DJDražen Jelašić
Dražen Jelašić
JBJadranka Bozikov
Jadranka Bozikov
We conducted a retrospective study at the Department of Paediatric Cardiology of the University Hospital Centre Rebro, Zagreb, over the period from 1988 to 1998, so as to assess the epidemiology of childhood cardiomyopathies. The patients were categorized according to the guidelines of the Task Force on Cardiomyopathies of the World Health Organization and the International Society and Federation of Cardiology. We identified 121 infants, children and adolescents as having cardiomyopathy, giving an average occurrence for all cardiomyopathies of 38.81 for each 10,000 patients examined in our outpatient clinics for paediatric cardiology. Of the patients, 50 were female (41.3%) and 71 were male (58.7%). The cardiomyopathy was of the dilated variant in 52 patients (42.9%), with 43 patients (35.5%) having hypertrophic cardiomyopathy, and 6 patients (4.8%) identified with restrictive cardiomyopathy. We encountered no patients with arrhythmogenic right ventricular cardiomyopathy. In nine patients (7.4%), it proved impossible to classify the cardiomyopathy. We placed 11 patients (9.0%) in the group of specific cardiomyopathies. Most of those with dilated cardiomyopathy had been diagnosed prior to the age of 3 years (RR 1.9, 95% CI 1.4–2.47). There were no statistically significant differences in the incidences of dilated as compared to hypertrophic cardiomyopathy (Z 0.923, p = 0.1779), but we encountered a significantly lower occurrence of restrictive cardiomyopathy (Z 6.044, p < 0.001). Of those with hypertrophic cardiomyopathy, 15 patients (34.8%) had the asymmetric variant, while 28 patients (65.2%) exhibited the concentric form. During the period of follow-up, 10 patients died, 4 with dilated cardiomyopathy, 4 with hypertrophic cardiomyopathy, 1 with restrictive cardiomyopathy, and 1 with a specific cardiomyopathy. We encountered 12 (9.9%) patients who, besides cardiomyopathies, also suffered from neuromuscular disorders. Most of these had dilated cardiomyopathy. Mitochondrial disorders, in contrast, were more frequently found in patients with hypertrophic cardiomyopathy.

21 August 2002 in Human Mutation
Verified
Journal Article
Open access
PDF file
SHSilva Hećimović
Silva Hećimović
NKNataša Klepac
Nataša Klepac
JVJelena Vlašić
Jelena Vlašić
AVAleksandar Vojta
Aleksandar Vojta
DJDolores Janko
Dolores Janko
Krešimir PavelićKrešimir Pavelić
Krešimir Pavelić
This study presents the first molecular data on the basis and the origin of Huntington disease in Croatia and is the first such analysis performed among a Slavic population. We analyzed three trinucleotide polymorphisms in the HD gene: CAG, CCG and GAG Δ2642 (E2642del) triplets. Analysis of the CAG repeat size among 44 Huntington patients (39‐66 CAGs) and 51 normal individuals (9‐34 CAGs) showed that the range of the repeats was similar to previous findings. The frequency of the CCG and Δ2642 polymorphic alleles on N and HD chromosomes was found to correlate well with earlier reports for Western European populations. We found significance for both the CCG7 allele (p=0.004) and the Δ2642 allele (p<0.001) among HD chromosomes. The CCG7 allele was overpresented among affected chromosomes (94.6%), but was also the most frequent CCG allele among normal chromosomes (66.7%). Interestingly, the Δ2642 allele was present on 40.5% HD chromosomes compared to only 9.8% of control chromosomes. Our results indicate that HD mutations in Croatia could be of the same origin as in Western populations and also support the multi‐step hypothesis for generating new HD alleles. Similar frequencies and distributions of both the CCG and the Δ2642 polymorphisms in Croatia and Western European normal chromosomes indicate that the prevalence rate of HD in Croatia may be as high as in Western populations. Since we estimated a lower prevalence rate (1 : 100,000), we assume that there are still many misdiagnosed and/or unrecognized cases of Huntington disease in Croatia.